AHF: Science Wins Out with EU on AstaZeneca Vaccine

LOS ANGELES--(BUSINESS WIRE)--After a temporary suspension of AstraZeneca vaccine across several EU countries due to concerns about rare adverse reactions, many nations plan to restart vaccinations following European Medicines Agency’s (EMA) conclusion that the benefits of the vaccine far outweigh the risks. AIDS Healthcare Foundation (AHF), the largest global HIV/AIDS organization praised the decision following EMA’s due-diligence review of facts as a win for science. Among 20 million people w

Click to view original post